Topical Therapy for the Treatment of Migraines, Muscle Sprains, Muscle Spasms, Spasticity and Related Conditions
AssigneeAfgin Pharma, LLC
InventorRonald AUNG-DIN
Life of this patent
Estimating the term…
Abstract
The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related migraines and related conditions associated with muscle tension and pain with a therapeutically effective amount of an ergot alkaloid, skeletal muscle relaxant, serotonin agonist, combinations thereof, pharmaceutically acceptable salt thereof, prodrugs thereof or derivative thereof.
Claims26
1-73. (canceled)
A method of treating migraines, cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches and tension related migraines with a topical formulation comprising applying a therapeutically effective amount of an active agent(s) comprising a skeletal muscle relaxant or a pharmaceutically acceptable salt thereof onto the skin of a human patient experiencing an acute condition selected from the group consisting of migraine, cluster headache, muscle sprain, muscle spasm, spasticity, tension headache and tension related migraine at the posterior cervical area in close proximity to the brain stem, such that the unit dose provides a therapeutic effect within about 15 to about 30 minutes after topical administration to the human patient.
A method of treating migraines, cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches and tension related migraines with a topical formulation comprising applying a therapeutically effective amount of a skeletal muscle relaxant or a pharmaceutically acceptable salt thereof incorporated into an immediate release pharmaceutically acceptable carrier onto the skin of a human patient at the posterior cervical area in close proximity to the brain stem, wherein the human patient is experiencing an acute condition selected from the group consisting of migraine, cluster headache, muscle sprain, muscle spasm, spasticity, tension headache and tension related migraine, such that the unit dose provides a therapeutic effect within about 30 minutes after the topical administration.
Dependencies are inferred from the claim text.